Indraprastha Medical Corporation Ltd vs Nephro Care India Ltd Stock Comparison
Indraprastha Medical Corporation Ltd vs Nephro Care India Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Indraprastha Medical Corporation Ltd is ₹ 299.95 as of 23 Oct 15:30
. The P/E Ratio of Indraprastha Medical Corporation Ltd is 0 as of March 2026
.The P/E Ratio of Nephro Care India Ltd is 25.4 as of March 2026
. The Market Cap of Indraprastha Medical Corporation Ltd is ₹ 0 crore as of March 2026
.The Market Cap of Nephro Care India Ltd is ₹ 85.32 crore as of March 2026
. The Revenue of Indraprastha Medical Corporation Ltd is ₹ 0 crore as of Jun '25
.The Revenue of Nephro Care India Ltd is ₹ 17.39 crore as of Jun '25
. The EBITDA of Indraprastha Medical Corporation Ltd is ₹ 0 crore as of Jun '25
.The EBITDA of Nephro Care India Ltd is ₹ 0.66 crore as of Jun '25
. The Net Profit of Indraprastha Medical Corporation Ltd is ₹ 0 crore as of Jun '25
.The Net Profit of Nephro Care India Ltd is ₹ -0.65 crore as of Jun '25
. The Dividend Payout of Indraprastha Medical Corporation Ltd changed from 39.1 % on March 2022 to 19.97 % on March 2026 . This represents a CAGR of -12.57% over 5 yearsThe Dividend Payout of Nephro Care India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Indraprastha Medical Corporation Ltd
Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals.
The Hospital provides international standard medical care, offering a wide range of multi-specialty services.
Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics.
The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000.
IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi.
About Nephro Care India Ltd
Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal.
Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre.
Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients.
The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients.
The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.
FAQs for the comparison of Indraprastha Medical Corporation Ltd and Nephro Care India Ltd
Which company has a larger market capitalization, Indraprastha Medical Corporation Ltd or Nephro Care India Ltd?
Market cap of Indraprastha Medical Corporation Ltd is 2,749 Cr while Market cap of Nephro Care India Ltd is 136 Cr
What are the key factors driving the stock performance of Indraprastha Medical Corporation Ltd and Nephro Care India Ltd?
The stock performance of Indraprastha Medical Corporation Ltd and Nephro Care India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Indraprastha Medical Corporation Ltd and Nephro Care India Ltd?
As of October 25, 2026, the Indraprastha Medical Corporation Ltd stock price is INR ₹299.95. On the other hand, Nephro Care India Ltd stock price is INR ₹83.0.
How do dividend payouts of Indraprastha Medical Corporation Ltd and Nephro Care India Ltd compare?
To compare the dividend payouts of Indraprastha Medical Corporation Ltd and Nephro Care India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.